Latest news
Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:20 GMTLayoff Tracker: Ensoma cuts jobs, narrows focus to lead asset - BioSpaceBioSpace · Fri, 07 Aug 2026 07:00:00 GMTGrifols leverages its biopharmaceuticals division to raise profit to €227M in the first half - Diari ARADiari ARA · Tue, 28 Jul 2026 07:00:00 GMT